Astrid Irwanto

6.4k total citations
13 papers, 130 citations indexed

About

Astrid Irwanto is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Astrid Irwanto has authored 13 papers receiving a total of 130 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in Astrid Irwanto's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug-Induced Adverse Reactions (3 papers) and Autoimmune Bullous Skin Diseases (3 papers). Astrid Irwanto is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug-Induced Adverse Reactions (3 papers) and Autoimmune Bullous Skin Diseases (3 papers). Astrid Irwanto collaborates with scholars based in Singapore, Indonesia and United States. Astrid Irwanto's co-authors include Jianjun Liu, Woon‐Puay Koh, Jian‐Min Yuan, Mikael Hartman, Agus Salim, Ge Chen, Yun-Miao Guo, Jin‐Xin Bei, Bin Zhou and Qi-Sheng Feng and has published in prestigious journals such as Scientific Reports, Frontiers in Pharmacology and Breast Cancer Research.

In The Last Decade

Astrid Irwanto

13 papers receiving 127 citations

Peers

Astrid Irwanto
Mónica Erazo United States
B Chen China
M. Issa United States
Elly van Koolwijk Netherlands
Amy Foulkes United Kingdom
Astrid Irwanto
Citations per year, relative to Astrid Irwanto Astrid Irwanto (= 1×) peers Claire Le Houérou

Countries citing papers authored by Astrid Irwanto

Since Specialization
Citations

This map shows the geographic impact of Astrid Irwanto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Irwanto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Irwanto more than expected).

Fields of papers citing papers by Astrid Irwanto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Irwanto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Irwanto. The network helps show where Astrid Irwanto may publish in the future.

Co-authorship network of co-authors of Astrid Irwanto

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Irwanto. A scholar is included among the top collaborators of Astrid Irwanto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Irwanto. Astrid Irwanto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Verma, Rashmi, et al.. (2025). A feasibility study on implementing pre-emptive pharmacogenomics testing in outpatient clinics in Singapore (IMPT study). The Pharmacogenomics Journal. 25(1-2). 7–7. 1 indexed citations
2.
Irwanto, Astrid, et al.. (2024). The variation landscape of CYP2D6 in a multi-ethnic Asian population. Scientific Reports. 14(1). 16725–16725. 3 indexed citations
3.
Gan, Pamela, et al.. (2024). Development and validation of a pharmacogenomics reporting workflow based on the illumina global screening array chip. Frontiers in Pharmacology. 15. 1349203–1349203. 3 indexed citations
5.
Irwanto, Astrid, Alvin Yu Jin Ng, Benedict Yan, et al.. (2022). Variant landscape of the RYR1 gene based on whole genome sequencing of the Singaporean population. Scientific Reports. 12(1). 5429–5429. 3 indexed citations
6.
Fachiroh, Jajah, et al.. (2022). Allopurinol-Induced Stevens–Johnson Syndrome in Javanese Men With Positive HLA‐B*58:01. Frontiers in Genetics. 13. 839154–839154. 8 indexed citations
7.
Mahendra, Caroline, et al.. (2021). Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice. Frontiers in Pharmacology. 12. 684907–684907. 7 indexed citations
8.
Mahendra, Caroline, et al.. (2021). Wide Application of Minimally Processed Saliva on Multiple RT-qPCR Kits for SARS-CoV-2 Detection in Indonesia. Frontiers in Cellular and Infection Microbiology. 11. 691538–691538. 7 indexed citations
9.
Mahendra, Caroline, et al.. (2021). Validation of a Multi-Gene qPCR-Based Pharmacogenomics Panel Across Major Ethnic Groups in Singapore and Indonesia. Pharmacogenomics. 22(16). 1041–1056. 2 indexed citations
10.
Irwanto, Astrid, Ishak D. Irwan, Yonghu Sun, et al.. (2020). Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. PLoS neglected tropical diseases. 14(10). e0008746–e0008746. 20 indexed citations
11.
Sun, Yonghu, Baoqi Yang, Jia Nee Foo, et al.. (2018). Investigation of the predisposing factor of pemphigus and its clinical subtype through a genome‐wide association and next generation sequence analysis. Journal of the European Academy of Dermatology and Venereology. 33(2). 410–415. 13 indexed citations
12.
Irwanto, Astrid, Agus Salim, Jian‐Min Yuan, et al.. (2014). Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population. Breast Cancer Research. 16(3). R64–R64. 25 indexed citations
13.
Zhou, Bin, Astrid Irwanto, Yun-Miao Guo, et al.. (2012). Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma. Cancer Biology & Therapy. 13(10). 871–879. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026